Incidence of advanced-stage breast cancer in regular participants of a mammography screening program: a prospective register-based study
L. Khil, J. Heidrich, I. Wellmann, V. Kääb-Sanyal, S. Weigel, W. Heindel, H.W. Hense, O. Heidinger
BMC Cancer. 2020 Mar 4;20(1):174. doi: 10.1186/s12885-020-6646-5
Stratification of Breast Cancer Risk in Terms of the Influence of Age and Mammographic density
S. Weigel, W. Heindel, C. Dietz, U. Meyer-Johann, A. Graewingholt, W.H. Hense
Rofo. 2020 Feb 27. doi: 10.1055/a-1100-0016
High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer
U. Bick, C. Engel, B. Krug, W. Heindel, E. M. Fallenberg, K. Rhiem, D. Maintz, M. Golatta, D. Speiser, D. Rjosk-Dendorfer, I. Lämmer-Skarke, F. Dietzel, K. Werner, F. Schäfer, E. Leinert, S. Weigel, S. Sauer, S. Pertschy, T. Hofmockel, A. Hagert-Winkler, K. Kast, A. Quante, A. Meindl, M. Kiechle, M. Loeffler, R. K. Schmutzler, the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC)
Breast Cancer Res Treat (2019). doi: 10.1007/s10549-019-05152-9
Strukturierte und qualitätsgesicherte Früherkennung: Eine wichtige Säule im Kampf gegen Brustkrebs
W. Heindel, C. Verloh, S. Weigel
Onkologische Pharmazie; 21. Jahrgang; Nr. 1/2019; ISSN-Nr. 1437-8825
Time trend in programme sensitivity within the German mammography screening programme in North Rhine-Westphalia and Lower Saxony
B. Bokhof, L. Khil, I. Urbschat, L. Gnas, G. Hecht, O. Heidinger, W. Heindel, J. Kieschke, S. Weigel, H.W. Hense
Bundesgesundheitsbl (2018) 61: 1517. doi: 10.1007/s00103-018-2843-7
Higher Detection Rates of Biologically Aggressive Breast Cancers in Mammography Screening than in the Biennial Interval
A. Prange, B. Bokhof, P. Polzer, J. Tio, I. Radke, O. Heidinger, W. Heindel, S. Weigel
Rofo. 2018; 190. doi: 10.1055/a-0657-3970